[ad_1]
A new development in medicine has caught the attention of the whole world for its benefits. it’s about the vaccine American company candidate Novavax. Daniela Hozbor, biochemist, molecular biologist and specialist in vaccines, explained to MDZ Radio how it works and what features make it special.
Unlike those that have been authorized, this vaccine “It’s based on technology that directly includes proteins.” This distinguishes it, for example, from those manufactured by Moderna or Pfizer which “use genetic material”. Or Sputnik V ?? which uses viral vectors that carry a little SARS COV 2 or directly inactivated virus ??, he said Hozbor.
Thus the one developed by Novavax ? refers to proteins and is further formulated with an important adjuvant known as Matrix M ™. Specifically, the data shows that “the effectiveness against disease prevention exceeds 90%”.
But also, and what becomes very encouraging, is that among the positive cases that they had, some of them were infected with a worrying variant. ?? So the company says it is able to protect itself against some of the worrying variants of the SARS COV 2 virus, especially with the now called Alpha, i.e. UK ??
Another advantage is that it does not need very low temperatures for its conservation. So according to Hozbor, Can you handle any 2 or 8 degree cold chain as for the campaign of vaccination is this a very important aspect ??.
According to the specialist, the drug is already in phase 3. And during their study they included around 30,000 volunteers who were recruited from Mexico and various states in the United States.
.
[ad_2]
Source link